ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0232

Proximal Tubular ALOX5 Links Extracellular Matrix Homeostasis and Collagen Remodeling in Renal Fibrosis

Session Information

Category: CKD (Non-Dialysis)

  • 2203 CKD (Non-Dialysis): Mechanisms

Authors

  • Moon, Youngyoon, Kyung Hee University Hospital at Gangdong, Gangdong-gu, Seoul, Korea (the Republic of)
  • Lim, Hyun Ji, Kyung Hee University Hospital at Gangdong, Gangdong-gu, Seoul, Korea (the Republic of)
  • Hwang-Bo, Jeon, Kyung Hee University Hospital at Gangdong, Gangdong-gu, Seoul, Korea (the Republic of)
  • Lee, Tae Hoon, Kyung Hee University Hospital at Gangdong, Gangdong-gu, Seoul, Korea (the Republic of)
  • Jung, Su Woong, Kyung Hee University Hospital at Gangdong, Gangdong-gu, Seoul, Korea (the Republic of)
  • Kim, Yang Gyun, Kyung Hee University Hospital at Gangdong, Gangdong-gu, Seoul, Korea (the Republic of)
  • Lee, Sang ho, Kyung Hee University Hospital at Gangdong, Gangdong-gu, Seoul, Korea (the Republic of)
  • Moon, Ju young, Kyung Hee University Hospital at Gangdong, Gangdong-gu, Seoul, Korea (the Republic of)
Background

Renal fibrosis, a common histopathologic feature of chronic kidney disease, is characterized by excessive matrix accumulation caused by dysregulated of extracellular matrix (ECM) turnover. Arachidonate 5-lipoxygenase (ALOX5), a key enzyme in leukotriene biosynthesis, plays crucial roles in inflammatory cell recruitment and immune activation. Proximal tubule is the primary site where renal fibrosis begins after injury. Among ALOX5-derived leukotrienes, leukotriene D4 (LTD4) is a potent mediator acting through the cysteinyl leukotriene receptors expressed in tubular epithelial cells. However, the contribution of proximal tubular Alox5 to collagen deposition and ECM remodeling during renal fibrosis remains unclear.

Methods

Tamoxifen-inducible proximal tubule-specific Alox5 knockout mice were subjected to unilateral ureteral obstruction. Renal fibrosis, epithelial integrity, ECM remodeling, and immune activation were assessed by histological, immunohistochemical, imaging, molecular and biochemical analyses. HKC-8 cells were stimulated with Alox5-derived metabolites or TGF-β1, while Alox5 activity was inhibited by zileuton or siRNA silencing. Immune activation was further evaluated using CD11c-YFP mice and a THP-1 co-culture system in vitro.

Results

Proximal tubular Alox5 deletion markedly reduced tubulointerstitial fibrosis and preserved epithelial integrity in UUO kidneys, with decreased expression of CCL2, CXCL12 collagen I, and collagen III. Second Harmonic Generation and Fluorescence-Lifetime Imaging Microscopy imaging revealed that Alox5 deficiency preserved ECM organization and reduced collagen compaction. In vitro, LTD4 and 5-HETE increased total soluble collagen and inflammatory mediators, whereas pharmacologic or genetic inhibition of Alox5 attenuated these responses. Monocyte adhesion and avidity to HKC-8 cells were also reduced by Alox5 inhibition, and 3D imaging of CD11c-YFP kidneys showed decreased immune cell infiltration.

Conclusion

Proximal tubular epithelial Alox5 acts as a critical mediator linking inflammation and immune activation to structural remodeling during tubulointerstitial fibrosis. Alox5 blockade attenuates fibrosis by suppressing immune activation and inflammatory signaling, restoring ECM homeostasis, and reducing fibrotic collagen accumulation. These findings suggest that proximal tubule-specific Alox5 may serve as a promising upstream therapeutic target for renal fibrosis.